This study investigates the association between the blood urea nitrogen to albumin ratio (BAR) and cognitive impairment in PD patients, aiming to identify BAR as a potential biomarker for early detection and monitoring of cognitive decline. The gene discussed is ALB; the disease is Parkinson disease.